<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">92679</article-id>
<article-id pub-id-type="doi">10.7554/eLife.92679</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92679.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Stem Cells and Regenerative Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Differential regulation by CD47 and thrombospondin-1 of extramedullary erythropoiesis in mouse spleen</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Banerjee</surname>
<given-names>Rajdeep</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meyer</surname>
<given-names>Thomas J.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8190-9766</contrib-id>
<name>
<surname>Cam</surname>
<given-names>Margaret C.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0513-6225</contrib-id>
<name>
<surname>Kaur</surname>
<given-names>Sukhbir</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2481-2981</contrib-id>
<name>
<surname>Roberts</surname>
<given-names>David D.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health</institution>, Bethesda, MD, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>CCR Collaborative Bioinformatics Resource, Office of Science and Technology Resources, National Cancer Institute, National Institutes of Health</institution>, Bethesda, MD, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Shim</surname>
<given-names>Jiwon</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Seoul National University of Science and Technology</institution>
</institution-wrap>
<city>Seoul</city>
<country>Republic of Korea</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Banerjee</surname>
<given-names>Utpal</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence: <email>droberts@mail.nih.gov</email> Phone: 301-480-4369</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-11-22">
<day>22</day>
<month>11</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP92679</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-09-19">
<day>19</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-09-28">
<day>28</day>
<month>09</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.28.559992"/>
</event>
</pub-history>
<permissions>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
<ali:license_ref>https://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref>
<license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-92679-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from <italic>cd47</italic><sup><italic>−/−</italic></sup> mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens but significantly depleted in <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleens. Single cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119<sup>−</sup>CD34<sup>+</sup> progenitors and Ter119<sup>+</sup>CD34<sup>−</sup> committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc, Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleens relative to basal levels in wild type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="external-links">
<fn fn-type="dataset"><p>
<ext-link ext-link-type="uri" xlink:href="https://github.com/NIDAP-Community/Regulation-of-Extramedullary-Erythropoiesis-by-CD47-and-THBS1">https://github.com/NIDAP-Community/Regulation-of-Extramedullary-Erythropoiesis-by-CD47-and-THBS1</ext-link>
</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>CD47 is a counter-receptor for signal-regulatory protein-α (SIRPα)<sup><xref ref-type="bibr" rid="c1">1</xref></sup> and a component of a supramolecular membrane signaling complex for thrombospondin-1 that contains specific integrins, heterotrimeric G proteins, tyrosine kinase receptors, exportin-1, and ubiquilins.<sup><xref ref-type="bibr" rid="c2">2</xref>-<xref ref-type="bibr" rid="c5">5</xref></sup> CD47 binding to SIRPα on macrophages induces inhibitory signaling mediated by its cytoplasmic immunoreceptor tyrosine-based inhibition motifs that recruit and activate the tyrosine phosphatases SHP-1 and SHP-2.<sup><xref ref-type="bibr" rid="c1">1</xref></sup> Loss of this inhibitory signaling results in rapid splenic clearance of <italic>cd47</italic><sup><italic>−/−</italic></sup> mouse red blood cells (RBC) when transfused into a wild type (WT) recipient.<sup><xref ref-type="bibr" rid="c6">6</xref></sup> The species-specificity of CD47/SIRPα binding constitutes a barrier to interspecies blood transfusion and hematopoietic reconstitution.<sup><xref ref-type="bibr" rid="c7">7</xref>,<xref ref-type="bibr" rid="c8">8</xref></sup></p>
<p>CD47 forms nanoclusters on young RBC with limited binding to thrombospondin-1.<sup><xref ref-type="bibr" rid="c9">9</xref></sup> CD47 abundance decreases on aged RBCs, but CD47 on aging RBC forms larger and more dense clusters with increased ability to bind thrombospondin-1. CD47 on aging RBC also adopts an altered conformation.<sup><xref ref-type="bibr" rid="c10">10</xref></sup> Exposure of aged RBC to thrombospondin-1 further increased the size of CD47 clusters via a lipid raft-dependent mechanism. Conversely, CD47 cluster formation was limited on <italic>thbs1</italic><sup>−/−</sup> mouse RBC and associated with significantly increased RBC lifespan.<sup><xref ref-type="bibr" rid="c9">9</xref></sup></p>
<p>Liver and spleen are the main hematopoietic organs during embryonic development, whereas bone marrow assumes that responsibility after birth.<sup><xref ref-type="bibr" rid="c11">11</xref></sup> Induction of extramedullary hematopoiesis in adult spleen can compensate for pathological conditions that compromise hematopoiesis in bone marrow.<sup><xref ref-type="bibr" rid="c12">12</xref></sup> CD47 is highly expressed on proliferating erythroblasts during stress-induced erythropoiesis, and antibodies blocking either CD47 or SIRPα inhibited the required transfer of mitochondria from macrophages to developing erythroblasts in erythroblastic islands.<sup><xref ref-type="bibr" rid="c13">13</xref></sup> Notably, treatment with a CD47 antibody enhanced splenomegaly in the anemic stress model. Consistent with the absence of inhibitory SIRPα signaling that limits clearance of aged RBC,<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c15">15</xref></sup> <italic>cd47</italic><sup><italic>−/−</italic></sup> mice derived using CRISPR/Cas9 exhibited hemolytic anemia and splenomegaly.<sup><xref ref-type="bibr" rid="c16">16</xref></sup> Conversely, CD47-dependent thrombospondin-1 signaling regulates the differentiation of multipotent stem cells in a stage-specific manner,<sup><xref ref-type="bibr" rid="c17">17</xref>-<xref ref-type="bibr" rid="c19">19</xref></sup> and both <italic>thbs1</italic><sup><italic>−/−</italic></sup> and <italic>cd47</italic><sup><italic>−/−</italic></sup> mouse spleens have more abundant Sox2<sup>+</sup> stem cells and higher mRNA expression of the multipotent stem cell transcription factors Myc, Sox2, Oct4, and Klf4.<sup><xref ref-type="bibr" rid="c17">17</xref></sup> Therefore, both thrombospondin-1- and SIRPα-dependent CD47 signaling could alter erythropoiesis and contribute to spleen enlargement. Here, we utilized flow cytometry combined with bulk and single cell transcriptomics to examine extramedullary hematopoiesis in <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> mice, which revealed cooperative and opposing roles for CD47 and thrombospondin-1 to limit extramedullary erythropoiesis in spleen.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Upregulation of erythroid precursors in <italic>cd47</italic><sup><italic>−/−</italic></sup> mouse spleen</title>
<p>We confirmed the previously reported spleen enlargement in <italic>cd47</italic><sup>−/−</sup> mice,<sup><xref ref-type="bibr" rid="c18">18</xref>,<xref ref-type="bibr" rid="c20">20</xref></sup> but did not observe significant spleen enlargement in <italic>thbs1</italic><sup>−/−</sup> mice (supplemental Figure 1A). Enlargement of <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens could result from increased phagocytic clearance of RBC, as reported in <italic>cd47</italic><sup>−/−</sup> and <italic>sirpa</italic><sup><italic>−/−</italic></sup> mice treated with CpG<sup><xref ref-type="bibr" rid="c21">21</xref></sup> and aging <italic>cd47</italic><sup>−/−</sup> mice,<sup><xref ref-type="bibr" rid="c16">16</xref></sup> or increased cell numbers could result from the increased stem cell abundance in <italic>cd47</italic><sup>−/−</sup> spleens.<sup><xref ref-type="bibr" rid="c17">17</xref></sup> The spleen enlargement was associated with a significantly higher total spleen cell number in a single cell suspension after RBC lysis in <italic>cd47</italic><sup>−/−</sup> mice compared to WT and <italic>thbs1</italic><sup>−/−</sup> mice (<xref rid="fig1" ref-type="fig">Figure 1A</xref>).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Effects of <italic>Cd47</italic> or <italic>Thbs1</italic> gene disruption on spleen cell numbers and content of cells expressing erythropoietic precursor markers or the proliferation marker Ki67.</title>
<p>(A) Total spleen cell numbers in WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> C57BL/6 mice determined after lysis of RBC (mean±SEM, n =3). Flow cytometry was performed to analyze gated singlet spleen cells stained with Ter119 antibody (B), CD34 antibody (C), Sca1 antibody (D), Ki67 antibody with the indicated gating for high and low expression (E), cKit antibody (F), Epor antibody (G), Ermap antibody (H), Gypa antibody (I), or Aqp1 antibody (J). Further analysis of Epor (K,O), Ermap (L,P), Gypa (M,Q), and Aqp1 expression (N,R) was performed after gating for Ter119 expression. The percentages of cells positive for the indicated surface markers are presented (n = 3 or 4) P-values were determined using a two-tailed t test for two-samples assuming equal variances in GraphPad Prism. * = p&lt;0.05, ** = p&lt;0.01, *** = p&lt;0.001.</p></caption>
<graphic xlink:href="559992v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Our previous analysis of lineage-negative cells from WT and <italic>cd47</italic><sup>−/−</sup> spleens identified an increased abundance of NK cell precursors in <italic>cd47</italic><sup>−/−</sup> spleens.<sup><xref ref-type="bibr" rid="c18">18</xref></sup> Analysis of bulk RNAseq data of naïve WT and <italic>cd47</italic><sup><italic>−/−</italic></sup> spleen cells depleted for proerythroblasts through mature erythrocytes using the antibody Ter-119<sup><xref ref-type="bibr" rid="c22">22</xref></sup> and for cells bearing CD4, CD11b, CD11c, CD19, CD45R, CD49b, CD105, MHC Class II, and TCRγ/δ (Lin<sup>−</sup>CD8<sup>+</sup>) unexpectedly showed strong enrichment of a heme metabolism gene signature (supplemental Figure 1C), markers of stress-induced erythropoiesis<sup><xref ref-type="bibr" rid="c23">23</xref>,<xref ref-type="bibr" rid="c24">24</xref></sup> and adult definitive erythropoiesis<sup><xref ref-type="bibr" rid="c25">25</xref></sup> in the lineage-depleted <italic>cd47</italic><sup>−/−</sup> relative to the corresponding cells from WT spleens (<xref rid="tbl1" ref-type="table">Table 1</xref>, supplemental Figure 1B,D). Trim10 mRNA, which encodes an erythroid-specific RING finger protein required for terminal erythroid differentiation,<sup><xref ref-type="bibr" rid="c26">26</xref></sup> was elevated 50-fold. Higher Mki67 mRNA expression suggested increased proliferation among Lin<sup>−</sup> <italic>cd47</italic><sup><italic>−/−</italic></sup> spleen cells, which also expressed elevated mRNA levels of the major erythroid transcription factor Gata1.<sup><xref ref-type="bibr" rid="c27">27</xref></sup> Apart from increased Kit mRNA expression, however, mRNA expression of markers for multipotent erythroid progenitors including Anpep (CD13), Cd33, Sca1 and Gata2 was not elevated in the absence of CD47. These data suggested preferential accumulation of committed erythroid progenitors rather than multipotent erythroid progenitors in the <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens. CD47 regulates activities of the nuclear transport protein exportin-1,<sup><xref ref-type="bibr" rid="c5">5</xref></sup> and Xpo1 mRNA was also increased in <italic>cd47</italic><sup><italic>−/−</italic></sup> cells (<xref rid="tbl1" ref-type="table">Table 1</xref>). Exportin-1 is a Gata1 transcriptional target and promotes terminal erythroid differentiation by maintaining Gata1 in the nucleus,<sup><xref ref-type="bibr" rid="c28">28</xref></sup> which suggested a potential mechanism by which loss of CD47 could increase erythropoiesis.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Expression of erythropoiesis-associated genes in lineage-depleted <italic>cd47</italic><sup><italic>−/−</italic></sup> versus WT spleen cells</title></caption>
<graphic xlink:href="559992v1_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>To further characterize CD47-dependent spleen cells and the relevance of thrombospondin-1, single cell suspensions of depleted of mature RBC were analyzed using flow cytometry for expression of erythropoiesis-related cell surface and proliferation markers (<xref rid="fig1" ref-type="fig">Figure 1B-J</xref>, supplemental Figure 2). The percentages of Ter119<sup>+</sup> cells in singlet cells from <italic>cd47</italic><sup>−/−</sup> spleens was significantly higher than in WT or <italic>thbs1</italic><sup>−/−</sup> spleens (p = 0.0061 and 0.0322 respectively, <xref rid="fig1" ref-type="fig">Figure 1B</xref>). CD34 is expressed on multipotent through the CFU-E erythroid progenitors and was expressed a significantly higher percentage on <italic>cd47</italic><sup>−/−</sup> versus WT or <italic>thbs1</italic><sup>−/−</sup> cells (p = 0.0008 and 0.0001 respectively, <xref rid="fig1" ref-type="fig">Figure 1C</xref>), whereas the multipotent progenitor marker Sca1 was expressed in a smaller percentage of <italic>cd47</italic><sup><italic>−/−</italic></sup> versus WT or <italic>thbs1</italic><sup>−/−</sup> spleen cells (p = 0.0001 and 0.0009 respectively, <xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Effects of <italic>Cd47</italic> or <italic>Thbs1</italic> gene disruption on the percentage of Ter119<sup>+</sup> and Ter119<sup><italic>−</italic></sup> spleen cells expressing markers of multipotent and committed erythroid precursors and cell proliferation.</title>
<p>Spleen cells isolated from WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> mice were costained with Ter119 antibody along with cKit, Ki67, Sca1 Ermap, Gypa, Epor or Aqp1 antibodies and acquired on an LSRFortessa SORP. After gating for singlet cells, the percentages of Ter119<sup>+</sup> and Ter119<sup>−</sup> cells positive for stem cell markers cKit (A) and Sca1 (B), high or low levels of the proliferation marker Ki67 (C,D), were compared among WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> mouse spleens (n = 3-4). The proliferation of CD34<sup>+</sup> and CD34<sup>−</sup> populations of Ter119<sup>+</sup> spleen cells from WT, <italic>cd47</italic><sup><italic>−/−</italic></sup>, <italic>thbs1</italic><sup><italic>−/−</italic></sup> mice was evaluated by staining with CD34, Ter119 and Ki67 antibodies. Ter119<sup>+</sup>CD34<sup>+</sup> cells (E), Ter119<sup>+</sup>CD34<sup>−</sup> cells (F), and Ter119<sup>−</sup>CD34<sup>+</sup> cells (G) were also quantified (left panels) and analyzed for the proliferation marker Ki67 (center and right panels). P-values were determined using a two-tailed t test for two-samples assuming equal variances in GraphPad Prism. * = p&lt;0.05, ** = p&lt;0.01, *** = p&lt;0.001</p></caption>
<graphic xlink:href="559992v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>A higher percentage of <italic>cd47</italic><sup>−/−</sup> cells expressed the proliferation marker Ki67 at low but not high levels compared to WT or <italic>thbs1</italic><sup>−/−</sup> spleen cells (p = 0.0024 and 0.0003 respectively, <xref rid="fig1" ref-type="fig">Figure 1E</xref>). c-Kit signaling is crucial for normal hematopoiesis and is expressed in multipotent progenitors through CFU-E,<sup><xref ref-type="bibr" rid="c29">29</xref>,<xref ref-type="bibr" rid="c30">30</xref></sup> but the percentage of cKit positive cells was higher only in <italic>thbs1</italic><sup>−/−</sup> spleen cells (<xref rid="fig1" ref-type="fig">Figure 1F</xref>).</p>
<p>Erythrocyte lineage markers including Ermap, glycophorin A (Gypa), Epor and Aqp1 are established markers of stress-induced extramedullary erythropoiesis.<sup><xref ref-type="bibr" rid="c24">24</xref></sup> The erythropoietin receptor (Epor), which is expressed in CFU-E through proerythroblasts, was expressed in significantly more <italic>cd47</italic><sup><italic>−/−</italic></sup> versus WT spleen cells (p = 0.0077) but in significantly fewer <italic>thbs1</italic><sup>−/−</sup> spleen cells (p = 0.0017 <xref rid="fig1" ref-type="fig">Figure 1G</xref>). Cells expressing the major RBC membrane glycoprotein Gypa, which accumulates in erythroblasts, Ermap, and Aqp1 showed similar significant increases in <italic>cd47</italic><sup>−/−</sup> spleen cells, whereas only Gyp1<sup>+</sup> and Aqp1<sup>+</sup> cells were significantly decreased in <italic>thbs1</italic><sup>−/−</sup> spleen cells (<xref rid="fig1" ref-type="fig">Figure 1H, I, J</xref>). Consistent with their known induction kinetics, most of the cells expressing these markers were Ter119<sup>+</sup>, and the alterations in their abundance observed in <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> spleens were restricted to Ter119<sup>+</sup> cells (<xref rid="fig1" ref-type="fig">Figure 1K-R</xref>). These results indicate an increased abundance of committed erythroid progenitors spanning CD34<sup>+</sup> progenitors through reticulocytes in the <italic>cd47</italic><sup><italic>−/−</italic></sup> spleen but depletion of the earlier Sca1<sup>+</sup> multipotent progenitors. Consistent with the decreased turnover of <italic>thbs1</italic><sup>−/−</sup> RBC,<sup><xref ref-type="bibr" rid="c9">9</xref></sup> cells expressing the committed erythroid markers Gypa, Epor, and Aqp1 were depleted in <italic>thbs1</italic><sup>−/−</sup> spleens.</p>
<p>Erythropoietin binding to Epor on early erythroid precursor cells stimulates their survival, proliferation, and differentiation by inducing the master transcriptional regulators Tal1, Gata1, and Klf1.<sup><xref ref-type="bibr" rid="c31">31</xref></sup> Tal1, Gata1, and Klf1, and Epor mRNAs were strongly up-regulated in <italic>cd47</italic><sup><italic>−/−</italic></sup> relative to WT spleens (<xref rid="tbl1" ref-type="table">Table 1</xref>). The increased proliferative response in the <italic>cd47</italic><sup><italic>−/−</italic></sup> cells is consistent with a significant increase in Epor<sup>+</sup> Ter119<sup>+</sup> <italic>cd47</italic><sup><italic>−/−</italic></sup> cells, contrasting with a significant decreased in their abundance in Ter119<sup>+</sup> <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells (<xref rid="fig1" ref-type="fig">Figure 1K</xref>). Epor expression was minimal and unchanged in the Ter119<sup>−</sup> population (<xref rid="fig1" ref-type="fig">Figure 1O</xref>), indicating that the Ter119 antigen is expressed in erythroid precursors that are responsive to erythropoietin. These data are consistent with increased extramedullary erythropoiesis in <italic>cd47</italic><sup><italic>−/−</italic></sup> and suppressed extramedullary erythropoiesis relative to WT in <italic>thbs1</italic><sup>−/−</sup> spleens.</p>
</sec>
<sec id="s2b">
<title>CD47-dependence of erythropoietic markers in Ter119<sup>+</sup> and Ter119<sup><italic>−</italic></sup> cells</title>
<p>The Ter119 antibody recognizes an antigen highly expressed in mouse proerythroblasts through mature erythrocytes.<sup><xref ref-type="bibr" rid="c22">22</xref></sup> Although Ter119 is a widely used erythroid lineage marker, its epitope does not map to a specific protein<sup><xref ref-type="bibr" rid="c22">22</xref></sup> and requires 9-O-acetylation of sialic acids that are present on several RBC glycoproteins.<sup><xref ref-type="bibr" rid="c32">32</xref></sup> Although no effect of CD47 on the abundance of cKit<sup>+</sup> cells was detected (<xref rid="fig1" ref-type="fig">Figure 1F</xref>), Kit mRNA was significantly enriched in lineage-negative <italic>cd47</italic><sup><italic>−/−</italic></sup> spleen cells (<xref rid="tbl1" ref-type="table">Table 1</xref>). To resolve this discrepancy, the percentage of cKit<sup>+</sup> cells was assessed in Ter119<sup>+</sup> and Ter119<sup>−</sup> populations (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). A higher percentage of the <italic>cd47</italic><sup><italic>−/−</italic></sup> cells were Ter119<sup>+</sup>cKit<sup>+</sup>. Consistent with <xref rid="fig1" ref-type="fig">Fig 1F</xref> and the elevation of multipotent stem cells in <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleen,<sup><xref ref-type="bibr" rid="c17">17</xref></sup> Ter119<sup>−</sup>cKit+ cells were elevated in <italic>thbs1</italic><sup>−/−</sup> spleens. Consistent with the bulk RNA sequencing data, Sca1<sup>+</sup> cells in spleen did not differ in the Ter119<sup>+</sup> cells and were less abundant in Ter119<sup>−</sup> cells from <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens relative to the same subset from WT (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). Consistent with the negative regulation of stem cell transcription factors in spleen by CD47-dependent thrombospondin-1 signaling,<sup><xref ref-type="bibr" rid="c17">17</xref></sup> these results support prior evidence that that loss of <italic>thbs1</italic> or <italic>cd47</italic> results in accumulation of early hematopoietic precursors that are Ter119<sup>−</sup> and demonstrates a <italic>cd47</italic><sup><italic>−/−</italic></sup> -specific enrichment of cKit<sup>+</sup>Ter119<sup>+</sup> committed erythroid precursors. Proliferating cells with low Ki67 expression were more abundant in the Ter119<sup>+</sup> and Ter119<sup>−</sup> populations of <italic>cd47</italic><sup><italic>−/−</italic></sup> cells relative to WT and <italic>thbs1</italic><sup>−/−</sup>cells, suggesting that loss of <italic>cd47</italic> but not <italic>thbs1</italic> increases the proliferation of committed erythroid precursors (<xref rid="fig2" ref-type="fig">Figure 2C, D</xref>).</p>
</sec>
<sec id="s2c">
<title>CD47 limits proliferation of Ter119<sup>+</sup>CD34<sup><italic>−</italic></sup> and Ter119<sup><italic>−</italic></sup>CD34<sup>+</sup> spleen cells</title>
<p>Although <xref rid="fig1" ref-type="fig">Figure 1</xref> demonstrated increased numbers of Ter119<sup>+</sup> and CD34<sup>+</sup> cells in <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens, further analysis revealed that more CD34<sup>+</sup> cells are Ter119<sup>−</sup> than Ter119<sup>+</sup> (<xref rid="fig2" ref-type="fig">Figure 2E,G</xref> left panels). Therefore, loss of CD47 upregulates both early Ter119<sup>−</sup>CD34<sup>+</sup> progenitors and more mature Ter119<sup>+</sup> progenitors, most of which have lost CD34 expression (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). Most of the increased proliferation of <italic>cd47</italic><sup><italic>−/−</italic></sup> spleen cells, indicated by Ki67 expression, was in the Ter119<sup>+</sup>CD34<sup>−</sup> subset (<xref rid="fig2" ref-type="fig">Figure 2F</xref>, center and right panels), but proliferating <italic>cd47</italic><sup><italic>−/−</italic></sup> cells were also enriched in the Ter119<sup>−</sup>CD34<sup>+</sup> population (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). These data indicate roles for more differentiated Ter119<sup>+</sup>/CD34<sup>−</sup> erythroid progenitors as well as earlier Ter119<sup>−</sup>/CD34<sup>+</sup> erythroid progenitors in mediating the increased extramedullary erythropoiesis in <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens.</p>
</sec>
<sec id="s2d">
<title>Identification of CD47-dependent erythroid precursor populations</title>
<p>Single cell RNA sequencing (scRNAseq) was used to further define effects of CD47 and thrombospondin-1 on erythroid precursors in spleen (supplemental Figures 3,4). Spleen cells from WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> mice were treated with immobilized antibodies to deplete monocytic, T, B, and NK cell lineages and mature RBC and subjected to scRNAseq analysis. Following alignment, the mRNA expression data were clustered in two dimensions using the t-distributed stochastic neighbor embedding (tSNE) method in NIDAP. The spleen cells clustered in 13 groups (<xref rid="fig3" ref-type="fig">Figure 3A</xref>).</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3:</label>
<caption><title>Effects of <italic>cd47</italic> and <italic>thbs1</italic> gene deletion on stem cell and erythroid precursor populations in mouse spleen identified using single cell RNA sequence analysis.</title>
<p>(A) tSNE clustering analysis of lineage-depleted spleen cells from WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup>mice. The encircled area contains erythroid cells (clusters 9) and stem cells (cluster 11). (B) Distribution of WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleen cells in each cluster of the tSNE plot. (C) High resolution tSNE plots showing the distribution of the multipotent stem cell markers CD34 and Ly6a (Sca1) and Gata2, the erythropoietic markers Kit and Epor, the proliferation marker Mki67, erythroid differentiation transcription factors Klf1 and Gata1, and erythroid differentiation and extramedullary erythropoiesis markers Ermap, Aqp1, Tmem56, Trim10, Gypa1, Spta1, Sptb, Ebp42, Xpo1, and RanBP2 in clusters 9 and 11. (D) Co-expression of the indicated erythropoiesis related genes in WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleen cells in cluster 9 was quantified and expressed as a percentage of the total cell number of each genotype in cluster 9.</p></caption>
<graphic xlink:href="559992v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Differential effects of <italic>cd47</italic> and <italic>thbs1</italic> gene deletion on mRNA expression levels in cluster 9 erythroid precursor cells and proliferation of CD34<sup><italic>−</italic></sup>Ter119<sup>+</sup>Kit<sup>+</sup> cells assessed by flow cytometry.</title>
<p>(A) Violin plots comparing mRNA expression levels of the indicated genes in <italic>cd47</italic><sup><italic>−/−</italic></sup>, <italic>thbs1</italic><sup><italic>−/−</italic></sup> and WT spleen cells in cluster 9. (B) Violin plots comparing mRNA expression levels of the indicated genes in <italic>cd47</italic><sup><italic>−/−</italic></sup>, <italic>thbs1</italic><sup><italic>−/−</italic></sup> and WT spleen cells in cluster 11. * = p&lt;0.05.</p></caption>
<graphic xlink:href="559992v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Cell type analysis using SingleR with Immgen and mouse RNAseq databases identified the main cell types in each cluster (supplemental Figure 4A). WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> cells clustered by genotype in the major residual T cell clusters 0, 1, and 2 but had similar distributions within clusters 9 and 11 (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). Immgen main cell type annotation identified cluster 9 and a subset of cluster 11 as stem cells, and mouse RNA seq annotation identified erythrocyte signatures mostly in cluster 9. Erythroid-specific markers were found mainly in cluster 9 (<xref rid="fig3" ref-type="fig">Figure 3C</xref> and supplemental Figures 4B, 5). Consistent with the flow data in <xref rid="fig1" ref-type="fig">figures 1</xref> and <xref rid="fig2" ref-type="fig">2</xref>, <italic>cd47</italic><sup><italic>−/−</italic></sup> cells were more abundant in cluster 9 (64%), and <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells were less abundant (15%) relative to WT cells (21%).</p>
<p>CD34 was expressed mostly in cluster 11 and to lower parts of cluster 9, whereas Ly6a (Sca1) was restricted to isolated cells in both clusters. Kit and Gata2, which are expressed by multipotent progenitors through CFU-E, were expressed in lower and middle areas of cluster 9 and to a limited degree in cluster 11 (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Epor, Gata1, Klf1, Ermap, Aqp1 and the proliferation marker Ki67 had similar distributions in cluster 9 (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Trim10 and the late erythroid markers Gypa, Tmem56, Epb42, Spta1, and Sptb were restricted to the upper regions of cluster 9 (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Therefore, erythroid differentiation within cluster 9 correlates with increasing TSNE-2 scores.</p>
<p>Similar high percentages of WT and <italic>cd47</italic><sup><italic>−/−</italic></sup> cells within cluster 9 expressed the erythroid lineage markers Klf1, Aqp1, Tfrc, Epor, Ermap, and Gata1, but percentages for some were lower in <italic>thbs1</italic><sup>−/−</sup> cells (supplemental Figure 6A). The average mRNA/cell for Tfrc and Ermap was significantly higher in <italic>cd47</italic><sup><italic>−/−</italic></sup> cells, whereas mRNAs encoding Klf1, Aqp1, Epor, and</p>
<p>Gata1 were significantly lower compared to WT in <italic>thbs1</italic><sup>−/−</sup> cells (<xref rid="fig4" ref-type="fig">Figure 4A</xref>, <xref rid="tbl2" ref-type="table">Table 2</xref>). Violin plots indicated that cells with the highest Mki67 mRNA expression were more abundant in <italic>cd47</italic><sup><italic>−/−</italic></sup> cluster 9, and the average expression was higher (p=3.5×10<sup>-5</sup>), but cells with high and low Mki67 had similar distributions in <italic>thbs1</italic><sup>−/−</sup> and WT cells (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). Mki67 expression levels were lower in cluster 11, and <italic>cd47</italic><sup><italic>−/−</italic></sup> cells had higher mean expression that WT, but and <italic>thbs1</italic><sup>−/−</sup> cells had lower Mki67 than WT (<xref rid="tbl2" ref-type="table">Table 2</xref>). Expression of Kit was also higher in <italic>cd47</italic><sup><italic>−/−</italic></sup> versus WT cells in cluster 9 (p=2.8×10<sup>-4</sup>). Although more <italic>cd47</italic><sup><italic>−/−</italic></sup> cells expressed Gata1 and Epor, the mean expression was not higher than in WT cells.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>Differential mRNA expression of erythropoietic, stem cell, and proliferation associated markers in WT, <italic>cd47</italic><sup><italic>−/−</italic></sup>, and <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells in clusters 9 and 11.</title></caption>
<graphic xlink:href="559992v1_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>Expression of Xpo1 and Ranbp2, which regulates activity of the Xpo1/Ran complex that stabilizes Gata1,<sup><xref ref-type="bibr" rid="c33">33</xref></sup> was significantly higher in cluster 9 than in cluster 11, and within cluster 9 the distribution of positive cells was similar to that for other markers of committed erythroid precursors (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). The average expression in cluster 9 was significantly higher in <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> cells compared to WT, whereas expression was less genotype-dependent in cluster 11 (<xref rid="fig4" ref-type="fig">Figure 4A,B</xref>, <xref rid="tbl2" ref-type="table">Table 2</xref>). Resolution of cluster 9 into CD34<sup>+</sup> and CD34<sup>−</sup> cells revealed that the CD47-dependent expression of Xpo1 and Ranbp2 was restricted to the CD34<sup>−</sup> population (supplemental Figure 6B). In contrast, expression of mRNA for RanBP1, which regulates the physical interaction of Xpo1 with CD47,<sup><xref ref-type="bibr" rid="c5">5</xref></sup> did not differ in <italic>cd47</italic><sup><italic>−/−</italic></sup> or <italic>thbs1</italic><sup>−/−</sup> cells in clusters 9 (<xref rid="tbl2" ref-type="table">Table 2</xref>). Nr3c1, a marker of adult definitive erythropoiesis,<sup><xref ref-type="bibr" rid="c25">25</xref></sup> and Ddx46, which is required for hematopoietic stem cell differentiation,<sup><xref ref-type="bibr" rid="c34">34</xref></sup> were among the genes with increased percentages of positive cells and significantly increased average expression in both <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> cells in cluster 9 (supplemental Figure 6A, <xref rid="tbl2" ref-type="table">Table 2</xref>). These genes also showed CD47-dependent expression in cluster 11.</p>
<p>The co-expression of mRNAs for erythropoietic genes was compared in cluster 9 cells from <italic>cd47</italic><sup>−/−</sup>, WT, and <italic>thbs1</italic><sup>−/−</sup> spleens (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). Small fractions of the WT CD34<sup>+</sup> cells expressed Gata1 and Klf1 mRNAs, 3.2% expressed Mki67, and none expressed Ermap. Consistent with the flow cytometry data in <xref rid="fig2" ref-type="fig">Figure 2</xref>, coexpression of the respective genes with CD34 was more frequent in <italic>cd47</italic><sup><italic>−/−</italic></sup> cells in cluster 9, but generally less in <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells. Notably, CD34<sup>+</sup> <italic>thbs1</italic><sup>−/−</sup> cells showed no Mki67 coexpression. In contrast, WT cells that expressed committed erythroid differential markers were highly proliferative. Coexpression of all these genes with Mik67 was more frequent in <italic>cd47</italic><sup><italic>−/−</italic></sup> cells compared to WT cells, but only for Kit and Ly6a in <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells. Coexpression of the erythroid transcription factors Gata1 and Klf1 was similarly increased in <italic>cd47</italic><sup>−/−</sup> cells but decreased in <italic>thbs1</italic><sup>−/−</sup> cells compared to the WT cells in cluster 9. The latter is consistent with the extended life span of <italic>thbs1</italic><sup><italic>−/−</italic></sup> RBC.<sup><xref ref-type="bibr" rid="c9">9</xref></sup> Kit coexpression with the erythroid lineage markers Ermap and Klf1 was moderately dependent on genotype, and Ly6a coexpression with these markers was decreased for <italic>cd47</italic><sup>−/−</sup> cells in cluster 9.</p>
</sec>
<sec id="s2e">
<title>Reclustering and analysis of cells expressing erythroid signature genes</title>
<p>Erythrocyte progenitor markers were expressed mainly within cluster 9, but some positive cells were scattered across the T cell clusters 0, 1, and 2 (supplemental figures 4B, 5). To determine whether the latter positive cells include relevant erythroid lineages that were missed in the initial clustering, the lineage markers Gypa, Ermap, Klf1, and Aqp1 were selected as an erythroid signature to calculate module scores (Supplemental figure 7). Cells expressing this signature based on module scores (<xref rid="fig5" ref-type="fig">Figure 5A</xref>) were then reclustered, yielding two major clusters in a UMAP projection (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). Immgen annotations predicted these represent T cells and stem cells (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). Mouse RNAseq annotation confirmed the T cell cluster and predicted the stem cell cluster to be of erythrocyte lineage (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> and <italic>thbs1</italic><sup>−/−</sup> cells were uniformly distributed throughout the erythroid cluster but segregated within the T cell cluster (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). <italic>Cd47</italic><sup><italic>−/−</italic></sup> cells were more abundant in the erythroid cluster (310%) and <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells were less abundant (70%) relative to WT cells.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Re-clustering of lineage-depleted spleen cells selected for expression of erythroid signature genes.</title>
<p>(A) tSNE plot showing the distribution of cells selected for expressing threshold levels of Gypa, Ermap, Klf1, and/or Aqp1. (B) Immgen and mouse RNAseq main cell type annotation of reclustered cells expressing the erythroid gene signature. Re-clustered cells are displayed in a UMAP projection. (C) Distribution of WT (blue), <italic>cd47</italic><sup><italic>−/−</italic></sup> (red), and <italic>thbs1</italic><sup><italic>−/−</italic></sup> cells (green) in the cluster UMAP projection. (D) Distribution of the multipotent stem cell markers CD34 and Ly6a (Sca1), erythropoietic markers Kit and Epor, the erythroid differentiation transcription factors Klf1 and Gata1, and erythroid differentiation and extramedullary erythropoiesis marker Aqp1, the proliferation marker Mik67, and the erythroid markers Ermap, Tfrc, Tmem56, Trim10, Gypa1, Spta1, Sptb, and Ebp42 in the T cell (lower left) and erythroid lineage cluster (upper right).</p></caption>
<graphic xlink:href="559992v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>A volcano plot indicated major differences in the transcriptomes of the two main clusters(Supplemental Figure 7B). Infrequent expression of Ermap, Klf1, and Aqp1 in the T cell cluster is consistent with previous reports of their expression in minor subsets of T cells<sup><xref ref-type="bibr" rid="c35">35</xref>-<xref ref-type="bibr" rid="c37">37</xref></sup> (<xref rid="fig5" ref-type="fig">Figure 5D</xref>).</p>
<p>The distribution of erythroid markers throughout the reclustered erythroid population was consistent with the results for cluster 9 (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). CD34<sup>+</sup> cells were concentrated in the lower region of the cluster. Consistent with the selection of calls based on expression of committed erythroid lineage genes, the cluster lacked Ly6a<sup>+</sup> cells. Kit was expressed by the CD34<sup>+</sup> cells and extended upward through the cluster. The upper cells showed increased expression of Epor, Klf1, Gata1, and Aqp1. Expression of the proliferation marker Mki67 was strongest in the upper region of the cluster and extended to cells that cells that expressed markers of more mature precursors including Ermap, Tfrc (transferrin receptor), and Tmem56. Trim10 mediates terminal differentiation and colocalized with mRNAs encoding glycophorin A, spectrins A and B, band 4.2. The upregulation of erythrocyte lineage markers coincided with more abundant <italic>cd47</italic><sup><italic>−/−</italic></sup> cells in this cluster, which supports the initial clustering and confirms increased extramedullary erythropoiesis in <italic>cd47</italic><sup>−/−</sup> mice.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>The properties of erythroid precursors that accumulate in <italic>cd47</italic><sup>−/−</sup> spleens are consistent with previous studies of stress induced extramedullary erythropoiesis associated with malaria or trypanosome infections.<sup><xref ref-type="bibr" rid="c23">23</xref>,<xref ref-type="bibr" rid="c24">24</xref></sup> In addition to containing elevated NK precursors.<sup><xref ref-type="bibr" rid="c18">18</xref></sup>, the present data demonstrate that <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens contain more abundant erythroid precursors that are Ter119<sup>+</sup> by flow cytometry but presumably lack sufficient Ter119 for antibody bead depletion. These cells are present but less abundant in WT spleens, indicating that a low level of extramedullary erythropoiesis occurs in healthy mouse spleen. The Ter119<sup>+</sup>CD34<sup>−</sup> cells that accumulate in <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens are more proliferative and express multiple markers of committed erythroid precursors. In contrast, the same cells are depleted in <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleen, consistent with the function of thrombospondin-1 to facilitate the CD47/SIRPα-mediated turnover of aging RBC. These data also indicate that physiological levels of thrombospondin-1 support a basal level of erythropoiesis in WT spleen.</p>
<p>Notably, <italic>thbs1</italic><sup><italic>−/−</italic></sup> and <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens both contain more early erythroid precursors than are maintained basally in a WT spleen, consistent with the role of thrombospondin-1 signaling via CD47 to limit the expression of multipotent stem cell transcription factors in spleen.<sup><xref ref-type="bibr" rid="c17">17</xref></sup> Earlier erythroid precursors that are Ter119<sup>−</sup>Kit<sup>+</sup> accumulate in <italic>thbs1</italic><sup><italic>−/−</italic></sup> spleens. <italic>Thbs1</italic><sup><italic>−/−</italic></sup> and <italic>cd47</italic><sup><italic>−/−</italic></sup> cells express more Ddx46, which is required for differentiation of hematopoietic stem cells,<sup><xref ref-type="bibr" rid="c34">34</xref></sup> and Xpo1, which supports the erythropoietic function of Gata1.<sup><xref ref-type="bibr" rid="c28">28</xref></sup> Although Ter119<sup>+</sup> cells expressing markers of committed erythroid progenitors were depleted in <italic>thbs1</italic><sup><italic>−/−</italic></sup> compared to WT spleens, s. mRNAs for some markers of committed erythroid cells including Nr3c1 mRNA were elevated <italic>thbs1</italic><sup><italic>−/−</italic></sup> and <italic>cd47</italic><sup><italic>−/−</italic></sup> in cluster 9 cells. However, early progenitors express CD45R, and inclusion of this antibody in the negative selection cocktail should deplete early progenitors from the populations used for both RNAseq analyses. This may account for the lack of CD47-dependent CD34<sup>+</sup> cells in cluster 9.</p>
<p>One caveat in interpreting the CD47- and thrombospondin-1-dependence of the extramedullary erythropoiesis markers Ermap and Aqp1 in total spleen cells and the Ter119-depleted cells used for scRNAseq is that both are also expressed in minor subsets of T cells.<sup><xref ref-type="bibr" rid="c37">37</xref></sup> The reclustering analysis confirmed that these erythropoietic markers are expressed in a minor T cell population, which notably also showed CD47-dependent gene expression changes. This may also account for the differences in CD47-dependence of erythropoietic marker expression observed by flow cytometry in Ter119<sup>+</sup> cells but not in total spleen cells or Ter119<sup>−</sup> spleen cells. In addition to assessing extramedullary erythropoiesis, the CD47-dependent erythropoiesis genes identified here may have translational utility. Therapeutics designed to inhibit function of CD47 have entered clinical trials for treating cancer, but anemia associated with loss of inhibitory SIRPα signaling in macrophages has been a frequent side effect for the first generation of these therapeutics.<sup><xref ref-type="bibr" rid="c38">38</xref></sup> In addition to their accumulation in spleens of <italic>cd47</italic><sup>−/−</sup> mice, erythroid precursors may also appear in circulation, suggesting that some of the CD47-dependent erythroid genes identified in this study may be useful biomarkers for assessing side effects of CD47-targeted therapeutics.</p>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Mice and cells</title>
<p>WT, <italic>cd47</italic><sup><italic>−/−</italic></sup> (B6.129S7-Cd47tm1Fpl/J), and <italic>thbs1</italic><sup><italic>−/−</italic></sup> (B6.129S2-<italic>Thbs1</italic><sup><italic>tm1Hyn</italic></sup>/J) mice were obtained from The Jackson Laboratory, backcrossed on the C57BL/6 background, and maintained under specific pathogen free conditions. All animal experiments were carried out in strict accordance with the Recommendations for the Care and Use of Laboratory Animals of the National Institutes of Health under a protocol approved by the NCI Animal Care and Use Committee. Age matched 8-12 week old mice were used for experiments except where noted.</p>
<p>Spleens were removed from the mice and homogenized in HBSS and passed through a 70 μm mesh (Sigma, CLS431751) to remove debris. The cell suspension was treated with ACK lysis buffer for 4 minutes to lyse the RBC. The suspensions were centrifuged and washed twice with cold HBSS. Aliquots of single cell suspensions were stained using trypan blue and counted to assess viability.</p>
</sec>
<sec id="s4b">
<title>Flow cytometry</title>
<p>Single-cell suspensions from spleens were stained by incubation for 30 min at 4° C using optimized concentrations of antibodies: CD34-APC and Ter119-APC, cKit-PE and PE/Cy7, Sca1-PE/Cy7, Ki67-Percp/Cy5.5 and AlexaFl647 (Biolegend). Non-tagged Ermap, Gypa, Aqp1 (Thermofisher) and Epor (Bios Inc.) antibodies were detected using secondary goat anti-rabbit AF594 antibodies. Stained single cell suspensions were acquired on an LSRFortessa SORP (BD Biosciences), and data were analyzed using FlowJo software (Tree Star). A total of 2×10<sup><xref ref-type="bibr" rid="c5">5</xref></sup> gated live events were acquired for each analysis. Isotype and unstained controls were used to gate the desired positive populations.</p>
</sec>
<sec id="s4c">
<title>Single cell RNA sequencing (scRNAseq)</title>
<p>Single cell suspensions from WT, <italic>thbs1</italic><sup><italic>−/−</italic></sup> and <italic>cd47</italic><sup><italic>−/−</italic></sup> spleens were depleted of all mature hematopoietic cell lineages including erythroblasts and mature RBC by passing through CD8a (Ly-2) microbeads and CD8a+ T Cell Isolation Kit, mouse (Miltenyi Biotec). Single cell suspensions were incubated with the supplied antibody cocktail of the CD8+ T cell isolation kit for 15 min. on ice and then passed through the column as per manufacturer’s instructions. The flow through combined with 3 washes was centrifuged, and the cells were incubated with the CD8a (Ly-2) microbeads and then passed through magnetic columns to obtain lineage-depleted cell populations. Capture &amp; Library Preparation for single cell end-counting gene expression using the 10X Genomics platform was performed by the Single Cell Analysis Facility (CCR). Data analysis was performed using the Seurat workflow (v.3.1.5).<sup><xref ref-type="bibr" rid="c39">39</xref></sup> Cell types were called using SingleR (v.1.0) <sup><xref ref-type="bibr" rid="c40">40</xref></sup> and Immgen and Mouse RNAseq databases.</p>
<sec id="s4c1">
<title>Capture &amp; Library Preparation</title>
<p>The cell samples received two washes in 1 mL of ice-cold PBS to remove any ambient contaminating mRNA from the suspension. The sample volume was reduced to ∼100 μL, and the sample concentration and viability were assessed using the LunaFL fluorescent cell counter. the viability was more than 90% for all the samples. Samples were loaded according to the 10x 3’ v3 User guide with a single capture lane per sample targeting a recovery of 6,000 cells per lane. Cell partitioning completed successfully with uniform emulsion consistency and the reverse transcription PCR was run overnight. All subsequent steps of library preparation and Quality Control were performed as described in the 10X Genomics 3’ v3 Single Cell User Guide. After the RT step, the emulsion was broken, and amplification of the 10× barcoded cDNA was completed. Amplified cDNA was then used for the construction of 3′ gene expression libraries. Each cDNA library was sequenced on a NovaSeq platform (Illumina) to generate 150-bp paired-end reads.</p>
</sec>
<sec id="s4c2">
<title>Data Analysis</title>
<p>We set filters to exclude genes found in fewer than 3 cells, cells with fewer than 200 genes, cells with fewer than 500 UMI, cells with complexity (genes/UMI) lower than 0.5, and cells exceeding 3 median absolute deviations for both mitochondrial expression percentage and the number of genes per cell. The dimensionality reduction plots were based on 22 principal components. We chose a clustering resolution of 0.2 and found two clusters (9 and 11, <xref rid="fig3" ref-type="fig">Figures 3</xref>) to contain most of the RBC progenitor cells this dataset. Downstream analysis and visualization were performed within the NIH Integrated Analysis Platform (NIDAP) using R programs developed on the Foundry platform (Palantir Technologies) (Supplemental Figures 2 through 4, 6). Additionally, RBC progenitor markers (Gypa, Ermap, Klf1, and Aqp1) were used to construct a module score by which likely RBC progenitor cells were identified using a manually set threshold, filtered, and further analyzed by filtering (<xref rid="fig4" ref-type="fig">Figure 4</xref>) and reclustering (<xref rid="fig5" ref-type="fig">Figure 5</xref>) to include only those cells (Supplemental Figure 7).</p>
</sec>
</sec>
<sec id="s4d">
<title>Bulk RNAseq</title>
<sec id="s4d1">
<title>Sample preparation from mouse spleens</title>
<p>Cells were isolated from spleens of 4–6-week-old WT and <italic>cd47</italic><sup><italic>-/-</italic></sup> C57Bl/6J mice (n=4). Cell isolation buffer contained phosphate-buffered saline (PBS), pH 7.2, 0.5% bovine serum albumin (BSA), and 2 mM EDTA and kept on ice. The buffer was filtered using Corning® 50 mL Tube Top Vacuum Filter System, 0.22 μm Pore 13.6cm<sup><xref ref-type="bibr" rid="c2">2</xref></sup> CA Membrane, Sterile (Corning). Dissected spleens were immediately placed in Petri dishes containing PBS (Gibco), and homogenized by pressing spleens through a 70 μm cell strainer using the back of plastic transfer pipettes (Sigma) with 5 ml of buffer. Mature RBC were lysed using 1 ml of ACK lysis buffer (Quality Biologicals) at room temperature for 5 minutes according to the manufacturer’s instructions.</p>
</sec>
<sec id="s4d2">
<title>Isolation and RNAseq analysis of lineage depleted populations containing CD8<sup>+</sup> T cells</title>
<p>Naïve CD8-enriched lineage-depleted spleen cells were prepared using the CD8a+ T Cell Isolation Kit. Clumps of cells were removed using 30 μm Pre-Separation Filters. The suspension was subjected to negative selection of CD8<sup>+</sup> T cells by incubating with biotin-conjugated monoclonal antibodies against CD4, CD11b, CD11c, CD19, CD45R (B220), CD49b (DX5), CD105, MHC Class II, Ter-119, and TCRγ/δ and passing through columns to deplete the indicated lineages according to manufacturer’s instructions (Miltenyi Biotec 130-104-075). The freshly isolated CD8<sup>+</sup> T cells plus unselected lineages were washed with filtered phosphate-buffered saline (PBS), pH 7.2, containing 0.5% bovine serum albumin (BSA), and 2 mM EDTA. The cells were immediately placed at -80 °C until the RNA was extracted, subjected to RNAseq analysis, and analyzed for differential gene expression using the NIDAP pipeline as described.<sup><xref ref-type="bibr" rid="c41">41</xref></sup> Preranked gene set enrichment analysis of the Hallmark collection was performed using the t-statistic as ranking variable (Supplemental Figure 1). This analysis was also performed using R programs run on NIDAP.</p>
</sec>
</sec>
<sec id="s4e">
<title>Data Sharing Statement</title>
<p>Data supporting this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accessions GSE239430. Reviewers may access this embargoed data by using the following Reviewer Token: qzuzwawmhpenxel. The code used to produce bioinformatics results can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/NIDAP-Community/Regulation-of-Extramedullary-Erythropoiesis-by-CD47-and-THBS1">https://github.com/NIDAP-Community/Regulation-of-Extramedullary-Erythropoiesis-by-CD47-and-THBS1</ext-link>. Additional data may be found in a data supplement available with the online version of this article.</p>
</sec>
</sec>
<sec id="d1e1721" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1811">
<label>Supplemental figures</label>
<media xlink:href="supplements/559992_file02.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Dr. Michael Kelly at the Single Cell Analysis Facility for performing preliminary clustering and data analysis. This research was funded by the Intramural Research Program of the Center for Cancer Research, the National Cancer Institute, and National Institutes of Health (ZIA SC009172, D.D.R.).</p>
</ack>
<sec id="s5">
<title>Author Contributions</title>
<p>R. B.: designed research, performed research, analyzed data, wrote the manuscript</p>
<p>T. J. M.: analyzed data, wrote the manuscript</p>
<p>M. C. C.: analyzed data, wrote the manuscript</p>
<p>S. K.: designed research, performed research, analyzed data, wrote the manuscript</p>
<p>D. D. R.: funding, conceptualization, designed research, analyzed data, wrote the manuscript</p>
</sec>
<sec id="s6">
<title>Competing Interests</title>
<p>The authors declare no competing financial interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Matozaki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Murata</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Okazawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ohnishi</surname> <given-names>H.</given-names></string-name> <article-title>Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway</article-title>. <source>Trends Cell Biol</source>. <year>2009</year>;<volume>19</volume>:<fpage>72</fpage>–<lpage>80</lpage>. doi:S0962-8924(08)00286-9 [pii] <pub-id pub-id-type="doi">10.1016/j.tcb.2008.12.001</pub-id></mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Gao</surname> <given-names>A-G</given-names></string-name>, <string-name><surname>Lindberg</surname> <given-names>FP</given-names></string-name>, <string-name><surname>Finn</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Blystone</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Frazier</surname> <given-names>WA</given-names></string-name>. <article-title>Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin</article-title>. <source>J Biol Chem</source>. <year>1996</year>;<volume>271</volume>:<fpage>21</fpage>–<lpage>24</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Isenberg</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Annis</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Pendrak</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Ptaszynska</surname> <given-names>M</given-names></string-name>, <string-name><surname>Frazier</surname> <given-names>WA</given-names></string-name>, <string-name><surname>Mosher</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>:<fpage>1116</fpage>–<lpage>1125</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M804860200</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Soto-Pantoja</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Kaur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>CD47 signaling pathways controlling cellular differentiation and responses to stress</article-title>. <source>Crit Rev Biochem Mol Biol</source>. <year>2015</year>;<volume>50</volume>:<fpage>212</fpage>–<lpage>230</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10409238.2015.1014024</pub-id></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Kaur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Saldana</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Elkahloun</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Petersen</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Arakelyan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Jenkins</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Kuo</surname> <given-names>B</given-names></string-name>, <string-name><surname>Reginauld</surname> <given-names>B</given-names></string-name>, <string-name><surname>Jordan</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Zimmerberg</surname> <given-names>J</given-names></string-name>, <string-name><surname>Margolis</surname> <given-names>L</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>CD47 interactions with exportin-1 limit the targeting of m(7)G-modified RNAs to extracellular vesicles</article-title>. <source>J Cell Commun Signal</source>. <year>2022</year>;<volume>16</volume>:<fpage>397</fpage>–<lpage>419</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12079-021-00646-y</pub-id></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Oldenborg</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Zheleznyak</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>YF</given-names></string-name>, <string-name><surname>Lagenaur</surname> <given-names>CF</given-names></string-name>, <string-name><surname>Gresham</surname> <given-names>HD</given-names></string-name>, <string-name><surname>Lindberg</surname> <given-names>FP</given-names></string-name>. <article-title>Role of CD47 as a marker of self on red blood cells</article-title>. <source>Science</source>. <year>2000</year>;<volume>288</volume>:<fpage>2051</fpage>–<lpage>2054</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.288.5473.2051</pub-id></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>VerHalen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Madariaga</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Xiang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lan</surname> <given-names>P</given-names></string-name>, <string-name><surname>Oldenborg</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Sykes</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>YG</given-names></string-name>. <article-title>Attenuation of phagocytosis of xenogeneic cells by manipulating CD47</article-title>. <source>Blood</source>. <year>2007</year>;<volume>109</volume>:<fpage>836</fpage>–<lpage>842</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2006-04-019794</pub-id></mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Strowig</surname> <given-names>T</given-names></string-name>, <string-name><surname>Rongvaux</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rathinam</surname> <given-names>C</given-names></string-name>, <string-name><surname>Takizawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Borsotti</surname> <given-names>C</given-names></string-name>, <string-name><surname>Philbrick</surname> <given-names>W</given-names></string-name>, <string-name><surname>Eynon</surname> <given-names>EE</given-names></string-name>, <string-name><surname>Manz</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Flavell</surname> <given-names>RA</given-names></string-name>. <article-title>Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/-mice improves engraftment of human hematopoietic cells in humanized mice</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>:<fpage>13218</fpage>–<lpage>13223</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1109769108</pub-id></mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>YH</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>GY</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>YG</given-names></string-name>. <article-title>Aging-associated changes in CD47 arrangement and interaction with thrombospondin-1 on red blood cells visualized by super-resolution imaging</article-title>. <source>Aging Cell</source>. <year>2020</year>;<volume>19</volume>:<fpage>e13224</fpage>. doi:<pub-id pub-id-type="doi">10.1111/acel.13224</pub-id></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Burger</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hilarius-Stokman</surname> <given-names>P</given-names></string-name>, <string-name><surname>de Korte</surname> <given-names>D</given-names></string-name>, <string-name><surname>van den Berg</surname> <given-names>TK</given-names></string-name>, <string-name><surname>van Bruggen</surname> <given-names>R.</given-names></string-name> <article-title>CD47 functions as a molecular switch for erythrocyte phagocytosis</article-title>. <source>Blood</source>. <year>2012</year>;<volume>119</volume>:<fpage>5512</fpage>–<lpage>5521</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2011-10-386805</pub-id></mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>CH</given-names></string-name>. <article-title>Homeostatic and pathogenic extramedullary hematopoiesis</article-title>. <source>J Blood Med</source>. <year>2010</year>;<volume>1</volume>:<fpage>13</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.2147/JBM.S7224</pub-id></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="other"><string-name><surname>Cenariu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Iluta</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zimta</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Petrushev</surname> <given-names>B</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dirzu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tomuleasa</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bumbea</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zaharie</surname> <given-names>F.</given-names></string-name> <article-title>Extramedullary Hematopoiesis of the Liver and Spleen</article-title>. <source>J Clin Med</source>. <year>2021;10</year>. doi:<pub-id pub-id-type="doi">10.3390/jcm10245831</pub-id></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Yokomori</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chua</surname> <given-names>LH</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>DQ</given-names></string-name>, <string-name><surname>Miharada</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sanda</surname> <given-names>T</given-names></string-name>, <string-name><surname>Suda</surname> <given-names>T.</given-names></string-name> <article-title>Mitochondria transfer mediates stress erythropoiesis by altering the bioenergetic profiles of early erythroblasts through CD47</article-title>. <source>J Exp Med</source>. <year>2022</year>;<volume>219</volume>. doi:<pub-id pub-id-type="doi">10.1084/jem.20220685</pub-id></mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Fossati-Jimack</surname> <given-names>L</given-names></string-name>, <string-name><given-names>Azeredo</given-names> <surname>da Silveira</surname></string-name> S, <string-name><surname>Moll</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kina</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kuypers</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Oldenborg</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Reininger</surname> <given-names>L</given-names></string-name>, <string-name><surname>Izui</surname> <given-names>S.</given-names></string-name> <article-title>Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses</article-title>. <source>J Autoimmun</source>. <year>2002</year>;<volume>18</volume>:<fpage>17</fpage>–<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1006/jaut.2001.0563</pub-id></mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Lutz</surname> <given-names>HU</given-names></string-name>, <string-name><surname>Bogdanova</surname> <given-names>A.</given-names></string-name> <article-title>Mechanisms tagging senescent red blood cells for clearance in healthy humans</article-title>. <source>Front Physiol</source>. <year>2013</year>;<volume>4</volume>:<fpage>387</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2013.00387</pub-id></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>JI</given-names></string-name>, <string-name><surname>Park</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Kwak</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Ryu</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Kwon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Han</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Nam</surname> <given-names>KT</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>HW</given-names></string-name>, <string-name><surname>Kang</surname> <given-names>BC</given-names></string-name>. <article-title>CRISPR/Cas9-mediated knockout of CD47 causes hemolytic anemia with splenomegaly in C57BL/6 mice</article-title>. <source>Lab Anim Res</source>. <year>2018</year>;<volume>34</volume>:<fpage>302</fpage>–<lpage>310</lpage>. doi:<pub-id pub-id-type="doi">10.5625/lar.2018.34.4.302</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Kaur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Soto-Pantoja</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Stein</surname> <given-names>EV</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Elkahloun</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Pendrak</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Nicolae</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Nie</surname> <given-names>ZQ</given-names></string-name>, <string-name><surname>Levens</surname> <given-names>D</given-names></string-name>, <string-name><surname>Isenberg</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors</article-title>. <source>Scientific Reports</source>. <year>2013</year>;<volume>3</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep01673</pub-id></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="other"><string-name><surname>Nath</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Gangaplara</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pal-Nath</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mandal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Maric</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sipes</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Cam</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shevach</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus</article-title>. <source>Frontiers in Immunology</source>. <year>2018;9</year>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.02985</pub-id></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Porpiglia</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kraft</surname> <given-names>P</given-names></string-name>, <string-name><surname>Holbrook</surname> <given-names>CA</given-names></string-name>, <string-name><surname>de Morree</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gonzalez</surname> <given-names>VD</given-names></string-name>, <string-name><surname>Hilgendorf</surname> <given-names>KI</given-names></string-name>, <string-name><surname>Fresard</surname> <given-names>L</given-names></string-name>, <string-name><surname>Trejo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bhimaraju</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>PK</given-names></string-name>, <string-name><surname>Fantl</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Blau</surname> <given-names>HM</given-names></string-name>. <article-title>Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration</article-title>. <source>Cell Stem Cell</source>. <year>2022</year>;<volume>29</volume>:<fpage>1653</fpage>–<lpage>1668 e1658</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.stem.2022.10.009</pub-id></mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Bian</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>L</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>YL</given-names></string-name>, <string-name><surname>Lv</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Niu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tremblay</surname> <given-names>A</given-names></string-name>, <string-name><surname>Venkataramani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Culpepper</surname> <given-names>C</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Mansour</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gewirtz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kidder</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y.</given-names></string-name> <article-title>Cd47-Sirpalpha interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2016</year>;<volume>113</volume>:<fpage>E5434</fpage>–<lpage>5443</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1521069113</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Kidder</surname> <given-names>K</given-names></string-name>, <string-name><surname>Bian</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y.</given-names></string-name> <article-title>Inflammation Unrestrained by SIRPalpha Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-gamma</article-title>. <source>J Immunol</source>. <year>2020</year>;<volume>205</volume>:<fpage>2821</fpage>–<lpage>2833</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.2000652</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Kina</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ikuta</surname> <given-names>K</given-names></string-name>, <string-name><surname>Takayama</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wada</surname> <given-names>K</given-names></string-name>, <string-name><surname>Majumdar</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Weissman</surname> <given-names>IL</given-names></string-name>, <string-name><surname>Katsura</surname> <given-names>Y.</given-names></string-name> <article-title>The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage</article-title>. <source>Br J Haematol</source>. <year>2000</year>;<volume>109</volume>:<fpage>280</fpage>–<lpage>287</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2141.2000.02037.x</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="other"><string-name><surname>Thompson</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Tipney</surname> <given-names>H</given-names></string-name>, <string-name><surname>Brass</surname> <given-names>A</given-names></string-name>, <string-name><surname>Noyes</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kemp</surname> <given-names>S</given-names></string-name>, <string-name><surname>Naessens</surname> <given-names>J</given-names></string-name>, <string-name><surname>Tassabehji</surname> <given-names>M.</given-names></string-name> <article-title>Claudin 13, a member of the claudin family regulated in mouse stress induced erythropoiesis</article-title>. <source>PLoS One</source>. <year>2010;5</year>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0012667</pub-id></mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Delic</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wunderlich</surname> <given-names>F</given-names></string-name>, <string-name><surname>Al-Quraishy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Abdel-Baki</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Dkhil</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Arauzo-Bravo</surname> <given-names>MJ</given-names></string-name>. <article-title>Vaccination accelerates hepatic erythroblastosis induced by blood-stage malaria</article-title>. <source>Malar J</source>. <year>2020</year>;<volume>19</volume>:<fpage>49</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12936-020-3130-2</pub-id></mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Kingsley</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Greenfest-Allen</surname> <given-names>E</given-names></string-name>, <string-name><surname>Frame</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Bushnell</surname> <given-names>TP</given-names></string-name>, <string-name><surname>Malik</surname> <given-names>J</given-names></string-name>, <string-name><surname>McGrath</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Stoeckert</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Palis</surname> <given-names>J.</given-names></string-name> <article-title>Ontogeny of erythroid gene expression</article-title>. <source>Blood</source>. <year>2013</year>;<volume>121</volume>:<fpage>e5</fpage>–<lpage>e13</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2012-04-422394</pub-id></mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Harada</surname> <given-names>H</given-names></string-name>, <string-name><surname>Harada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>O’Brien</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Rice</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Naeve</surname> <given-names>CW</given-names></string-name>, <string-name><surname>Downing</surname> <given-names>JR</given-names></string-name>. <article-title>HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells</article-title>. <source>Mol Cell Biol</source>. <year>1999</year>;<volume>19</volume>:<fpage>3808</fpage>–<lpage>3815</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.19.5.3808</pub-id></mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Gutierrez</surname> <given-names>L</given-names></string-name>, <string-name><surname>Caballero</surname> <given-names>N</given-names></string-name>, <string-name><surname>Fernandez-Calleja</surname> <given-names>L</given-names></string-name>, <string-name><surname>Karkoulia</surname> <given-names>E</given-names></string-name>, <string-name><surname>Strouboulis</surname> <given-names>J.</given-names></string-name> <article-title>Regulation of GATA1 levels in erythropoiesis</article-title>. <source>IUBMB Life</source>. <year>2020</year>;<volume>72</volume>:<fpage>89</fpage>–<lpage>105</lpage>. doi:<pub-id pub-id-type="doi">10.1002/iub.2192</pub-id></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Guillem</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dussiot</surname> <given-names>M</given-names></string-name>, <string-name><surname>Colin</surname> <given-names>E</given-names></string-name>, <string-name><surname>Suriyun</surname> <given-names>T</given-names></string-name>, <string-name><surname>Arlet</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Goudin</surname> <given-names>N</given-names></string-name>, <string-name><surname>Marcion</surname> <given-names>G</given-names></string-name>, <string-name><surname>Seigneuric</surname> <given-names>R</given-names></string-name>, <string-name><surname>Causse</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gonin</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gastou</surname> <given-names>M</given-names></string-name>, <string-name><surname>Deloger</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rossignol</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lamarque</surname> <given-names>M</given-names></string-name>, <string-name><surname>Choucair</surname> <given-names>ZB</given-names></string-name>, <string-name><surname>Gautier</surname> <given-names>EF</given-names></string-name>, <string-name><surname>Ducamp</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vandekerckhove</surname> <given-names>J</given-names></string-name>, <string-name><surname>Moura</surname> <given-names>IC</given-names></string-name>, <string-name><surname>Maciel</surname> <given-names>TT</given-names></string-name>, <string-name><surname>Garrido</surname> <given-names>C</given-names></string-name>, <string-name><surname>An</surname> <given-names>X</given-names></string-name>, <string-name><surname>Mayeux</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mohandas</surname> <given-names>N</given-names></string-name>, <string-name><surname>Courtois</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hermine</surname> <given-names>O.</given-names></string-name> <article-title>XPO1 regulates erythroid differentiation and is a new target for the treatment of beta-thalassemia</article-title>. <source>Haematologica</source>. <year>2020</year>;<volume>105</volume>:<fpage>2240</fpage>–<lpage>2249</lpage>. doi:<pub-id pub-id-type="doi">10.3324/haematol.2018.210054</pub-id></mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Lennartsson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ronnstrand</surname> <given-names>L.</given-names></string-name> <article-title>Stem cell factor receptor/c-Kit: from basic science to clinical implications</article-title>. <source>Physiol Rev</source>. <year>2012</year>;<volume>92</volume>:<fpage>1619</fpage>–<lpage>1649</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00046.2011</pub-id></mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="other"><string-name><surname>Swaminathan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hwang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Winward</surname> <given-names>A</given-names></string-name>, <string-name><surname>Socolovsky</surname> <given-names>M.</given-names></string-name> <article-title>Identification and Isolation of Burst-Forming Unit and Colony-Forming Unit Erythroid Progenitors from Mouse Tissue by Flow Cytometry</article-title>. <source>J Vis Exp</source>. <year>2022</year>. doi:<pub-id pub-id-type="doi">10.3791/64373</pub-id></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Perreault</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Venters</surname> <given-names>BJ</given-names></string-name>. <article-title>Integrative view on how erythropoietin signaling controls transcription patterns in erythroid cells</article-title>. <source>Curr Opin Hematol</source>. <year>2018</year>;<volume>25</volume>:<fpage>189</fpage>–<lpage>195</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MOH.0000000000000415</pub-id></mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Mahajan</surname> <given-names>VS</given-names></string-name>, <string-name><surname>Alsufyani</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mattoo</surname> <given-names>H</given-names></string-name>, <string-name><surname>Rosenberg</surname> <given-names>I</given-names></string-name>, <string-name><surname>Pillai</surname> <given-names>S.</given-names></string-name> <article-title>Alterations in sialic-acid O-acetylation glycoforms during murine erythrocyte development</article-title>. <source>Glycobiology</source>. <year>2019</year>;<volume>29</volume>:<fpage>222</fpage>–<lpage>228</lpage>. doi:<pub-id pub-id-type="doi">10.1093/glycob/cwy110</pub-id></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Ritterhoff</surname> <given-names>T</given-names></string-name>, <string-name><surname>Das</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hofhaus</surname> <given-names>G</given-names></string-name>, <string-name><surname>Schroder</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Flotho</surname> <given-names>A</given-names></string-name>, <string-name><surname>Melchior</surname> <given-names>F.</given-names></string-name> <article-title>The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<fpage>11482</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms11482</pub-id></mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Hirabayashi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hozumi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Higashijima</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kikuchi</surname> <given-names>Y.</given-names></string-name> <article-title>Ddx46 is required for multi-lineage differentiation of hematopoietic stem cells in zebrafish</article-title>. <source>Stem Cells Dev</source>. <year>2013</year>;<volume>22</volume>:<fpage>2532</fpage>–<lpage>2542</lpage>. doi:<pub-id pub-id-type="doi">10.1089/scd.2012.0623</pub-id></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Su</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tian</surname> <given-names>X</given-names></string-name>, <string-name><surname>Lai</surname> <given-names>L.</given-names></string-name> <article-title>ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses</article-title>. <source>Cell Mol Immunol</source>. <year>2021</year>;<volume>18</volume>:<fpage>1920</fpage>–<lpage>1933</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41423-020-0494-8</pub-id></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Teruya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Okamura</surname> <given-names>T</given-names></string-name>, <string-name><surname>Komai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Inoue</surname> <given-names>M</given-names></string-name>, <string-name><surname>Iwasaki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sumitomo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Shoda</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yamamoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Fujio</surname> <given-names>K.</given-names></string-name> <article-title>Egr2-independent, Klf1-mediated induction of PD-L1 in CD4(+) T cells</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>:<fpage>7021</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-25302-1</pub-id></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Moon</surname> <given-names>C</given-names></string-name>, <string-name><surname>Rousseau</surname> <given-names>R</given-names></string-name>, <string-name><surname>Soria</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Hoque</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jang</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Trink</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sidransky</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mao</surname> <given-names>L.</given-names></string-name> <article-title>Aquaporin expression in human lymphocytes and dendritic cells</article-title>. <source>Am J Hematol</source>. <year>2004</year>;<volume>75</volume>:<fpage>128</fpage>–<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajh.10476</pub-id></mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Kaur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cicalese</surname> <given-names>KV</given-names></string-name>, <string-name><surname>Bannerjee</surname> <given-names>R</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>Preclinical and Clinical Development of Therapeutic Antibodies Targeting Functions of CD47 in the Tumor Microenvironment</article-title>. <source>Antib Ther</source>. <year>2020</year>;<volume>3</volume>:<fpage>179</fpage>–<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1093/abt/tbaa017</pub-id></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Butler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hoffman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Smibert</surname> <given-names>P</given-names></string-name>, <string-name><surname>Papalexi</surname> <given-names>E</given-names></string-name>, <string-name><surname>Satija</surname> <given-names>R.</given-names></string-name> <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>. <source>Nat Biotechnol</source>. <year>2018</year>;<volume>36</volume>:<fpage>411</fpage>–<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id></mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Aran</surname> <given-names>D</given-names></string-name>, <string-name><surname>Looney</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>E</given-names></string-name>, <string-name><surname>Fong</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hsu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Chak</surname> <given-names>S</given-names></string-name>, <string-name><surname>Naikawadi</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Wolters</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Abate</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Butte</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Bhattacharya</surname> <given-names>M.</given-names></string-name> <article-title>Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage</article-title>. <source>Nat Immunol</source>. <year>2019</year>;<volume>20</volume>:<fpage>163</fpage>–<lpage>172</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41590-018-0276-y</pub-id></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Nath</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Pal-Nath</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kaur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gangaplara</surname> <given-names>A</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Cam</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>DD</given-names></string-name>. <article-title>Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice</article-title>. <source>Oncoimmunology</source>. <year>2022</year>;<volume>11</volume>:<fpage>2111909</fpage>. doi:<pub-id pub-id-type="doi">10.1080/2162402X.2022.2111909</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92679.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shim</surname>
<given-names>Jiwon</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Seoul National University of Science and Technology</institution>
</institution-wrap>
<city>Seoul</city>
<country>Republic of Korea</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents a <bold>valuable</bold> finding on the cell composition in mouse spleen depleted for the CD47 receptor and its signaling ligand Thrombospondin in hematopoietic differentiation. The supporting evidence is <bold>convincing</bold> with analytical improvements on the individual contributions of the signaling components and with functional studies. This work has implications for the role of CD47/Thsp in extramedullary erythropoiesis in mouse spleen and will be of interest to researchers in cell signaling, transfusion medicine, and cell therapy.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92679.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
This study investigated the role of CD47 and TSP1 in extramedullary erythropoiesis by utilization of both global CD47-/- mice and TSP1-/- mice.</p>
<p>Strengths:</p>
<p>
Flow cytometry combined with spleen bulk and single-cell transcriptomics were employed. The authors found that stress-induced erythropoiesis markers were increased in CD47-/- spleen cells, particularly genes that are required for terminal erythroid differentiation. Moreover, CD47 dependent erythroid precursors population was identified by spleen scRNA sequencing. In contrast, the same cells were not detected in TSP1-/- spleen. These findings provide strong evidence to support the conclusion that the differential role of CD47 and TSP1 in extramedullary erythropoiesis in mouse spleen.</p>
<p>Weaknesses:</p>
<p>
Methods and data analysis are appropriate. However, some clarifications are required. The discussion section needs to be expanded.</p>
<p>
1). The sex of mice that were used in the study is unknown.</p>
<p>
2). In the method of Single-cell RNA sequencing (page 10), it mentioned that single cell suspensions from mouse spleens were depleted of all mature hematopoietic cell lineages by passing through CD8a microbeads and CD8a+ T cell isolation Kit. As described, it is confusing what cell types are obtained for performing scRNAseq. More information is required for clarity.</p>
<p>
3). The constitutive CD47 knockout mouse model is utilized in this study. The observed accumulation of erythroid precursors in the spleens of CD47-/- mice suggests a chronic effect of CD47 on spleen function. Can the current findings be extrapolated to acute scenarios involving CD47 knockdown or loss, as this may have more direct relevance to the potential side effects associated with anti-CD47-mediated cancer therapy? Please expand on this topic in the discussion section.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92679.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
The authors used existing mouse models to compare the effects of ablating the CD47 receptor and its signaling ligand Thrombospondin. The CD47-KO model used in this study was generated by Kim et al, 2018, where hemolytic anemia and splenomegaly was reported. This study analyzes the cell composition of the spleens from CD47-KO and Thsp-KO, focusing on early hematopoietic and erythroid populations. The data broadly shows that splenomegaly in the CD47-KO is largely due to an increase in committed erythroid progenitors as seen by Flow Cytometry and single-cell sequencing, whereas the Thsp-KO shows a slight depletion of committed erythroid progenitors but is otherwise similar to WT in splenic cell composition.</p>
<p>Strengths: The techniques used are appropriate for the study and the data support the main conclusions of the study. This study provides novel insights into a putative role of Thsp-CD47 signaling in triggering definitive erythropoiesis in the mouse spleen in response to anemic stress and constitutes a good resource for researchers seeking to understand extramedullary erythropoiesis.</p>
<p>Weaknesses: The Flow cytometry data alone supports the authors' main conclusion and single-cell sequencing confirms them but does not add further information, other than those already observed in the Flow data. The single-cell sequencing analysis and presentation could be improved by using alternate clustering methods as well as separating the data by genotype and displaying them in order for readers to fully grasp the nuanced differences in marker expression between the genotypes. Further, it is not clear from the authors' description of their results whether the increased splenic erythropoiesis is a direct consequence of CD47-KO or a response to the anemic stress in this mouse model. The enrichment of cKit+ Ter119+ Sca1- cells in CD47-KO indicates that these are likely stress erythroid progenitors. Another CD47-KO mouse model (Lindberg et al 1996) has no reported erythroid defects and was also not examined in this study.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92679.1.sa3</article-id>
<title-group>
<article-title>Author Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Banerjee</surname>
<given-names>Rajdeep</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meyer</surname>
<given-names>Thomas J.</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cam</surname>
<given-names>Margaret C.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8190-9766</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Kaur</surname>
<given-names>Sukhbir</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0513-6225</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>David D.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2481-2981</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer 1:</bold></p>
</disp-quote>
<p>1. The missing mouse gender information will be incorporated into the revised manuscript. For flow cytometry, two male and two female mice of each genotype were used. For single cell RNA sequencing, two female and one male mouse of each genotype were used. For the bulk RNA sequencing four male cd47−/− mice and four male wildtype mice were used.</p>
<p>2. The bulk RNA sequencing analysis identified elevated expression of erythropoietic genes in CD8+ spleen cells from cd47−/− versus wildtype mice that were obtained using magnetic bead depletion of all other lineages. Therefore, we used the same Miltenyi negative selection kit as the first step to prepare the cells for single cell RNA sequencing. These untouched cells were then depleted of most mature CD8 T cells using a Miltenyi CD8a(Ly2) antibody positive selection kit. An important consideration underlying this approach was recognizing that the commercial magnetic bead depletion kits used for preparing specific immune cell types are optimized to give relatively pure populations of the intended immune cells using wildtype mice. Our previous experience studying NK cell development in the cd47−/− mice taught us that NK precursors, which are rare in wildtype mouse spleens, accumulate in cd47−/− spleens and were not removed by the antibody cocktail optimized for wildtype spleen cells (Nath et al Front Immunol 2018). The present data indicate that erythroid precursors behave similarly.</p>
<p>3. Anemia is a prevalent side effect of several CD47 therapeutic antibodies being developed for cancer therapy. Anemia would be expected to induce erythropoiesis in bone marrow and possibly at extramedullary sites. Human spleen cells are not accessible to directly evaluate extramedullary erythropoiesis in cancer patients, but analysis of circulating erythroid precursors or liquid biopsy methods could be useful to detect induction of extramedullary erythropoiesis by these therapeutics. We are currently investigating the ability of CD47 antibodies to directly induce erythropoiesis using a human in vitro model.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer 2:</bold></p>
</disp-quote>
<p>1. The reviewer asked, “whether the increased splenic erythropoiesis is a direct consequence of CD47-KO or a response to the anemic stress in this mouse model.” Our data supports both a direct role for CD47 and an indirect role resulting from the response to anemic stress. We cited our previous publications describing increased Sox2+ stem cells in spleens of Cd47 and Thbs1 knockout mice, but we neglected to emphasize another study where we found that bone marrow from cd47−/− mice subjected to the stress of ionizing radiation exhibited more colony forming units for erythroid (CFU-E) and burst-forming unit-erythroid (BFU-E) progenitors compared to bone marrow from irradiated wildtype mice (Maxhimer Sci Transl Med 2009). Taken together, our published data demonstrates that loss of CD47 results in an intrinsic protection of hematopoietic stem cells from genotoxic stress. This function of CD47 is thrombospondin-1-dependent and is consistent with the up-regulation of early erythroid precursors in the spleens of both knockout mice but cannot explain why the Thbs1−/−  mice have fewer committed erythroid precursors than wildtype. We cited studies that documented increased red cell turnover in cd47−/− mice but less red cell turnover in Thbs1−/−  mice compared to wildtype mice. Increased red cell clearance in cd47−/− mice is mediated by loss of the “don’t eat me” function of CD47 on red cells. In wildtype mice, clearance is augmented by thrombospondin-1 binding to the clustered CD47 on aging red cells (Wang, Aging Cell 2020). Thus, anemic stress in the mouse strains studied here decreases in the order cd47−/− &gt; WT &gt; Thbs−/−. This is consistent with the increased committed erythroid progenitors reported here in cd47−/− spleens and decreased committed progenitors in the Thbs1−/− spleens.</p>
<p>2. The cd47−/− mice used for the current study are the same strain as those reported by Lindberg et al in 1996, with additional backcrossing onto a C57BL/6 background.</p>
</body>
</sub-article>
</article>